Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-039857
Date:2021-10-08
Issuer: KYMERA THERAPEUTICS, INC. (KYMR)
Original Submission Date:

Reporting Person:

MAINOLFI NELLO
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN, MA 02472

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-10-08 M 41,544 a $2.08 505,743 direct
COMMON STOCK 2021-10-08 S 21,236 d $55.56 484,507 direct
COMMON STOCK 2021-10-08 S 9,369 d $56.82 475,138 direct
COMMON STOCK 2021-10-08 S 2,078 d $57.29 473,060 direct
COMMON STOCK 2021-10-08 S 7,920 d $59.28 465,140 direct
COMMON STOCK 2021-10-08 S 670 d $60.32 464,470 direct
COMMON STOCK 2021-10-08 S 271 d $61.87 464,199 direct
COMMON STOCK 2021-10-11 M 6,456 a $2.08 470,655 direct
COMMON STOCK 2021-10-11 S 5,712 d $53.58 464,943 direct
COMMON STOCK 2021-10-11 S 744 d $54.50 464,199 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.08 2021-10-08 deemed execution date M 41,544 (d) 2029-11-13 common stock 41,544 $2.08 35,181 direct
STOCK OPTION (RIGHT TO BUY) 2.08 2021-10-11 deemed execution date M 6,456 (d) 2029-11-13 common stock 6,456 $2.08 28,725 direct
Footnotes
IDfootnote
f1 this sale was effected pursuant to a rule 10b5-1 trading plan adopted on november 6, 2020.
f2 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $55.10 to $56.09. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f3 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $56.19 to $57.185. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f4 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $57.20 to $58.14. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f5 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $58.90 to $59.81. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f6 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $59.91 to $60.61. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f7 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $53.19 to $54.16. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f8 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $54.28 to $54.60. full information regarding the number of shares sold at each separate price can be furnished to the sec staff upon request.
f9 the shares underlying this stock option shall vest upon the achievement of specified performance-based milestones.
WhaleWisdom Logo

Elevate your investments